244
Filana Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
211
FY23:
130
FY24:
137
FY25:
97.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.3
FY22:
23.6
FY23:
22.0
FY24:
21.0
FY25:
20.6
Total assets
Change from FY21 to FY25
millions USD
FY21:
267
FY22:
235
FY23:
152
FY24:
158
FY25:
118
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
12.5
FY22:
7.06
FY23:
14.2
FY24:
11.8
FY25:
43.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.33
FY22:
0.23
FY23:
0
FY24:
0.08
FY25:
0.12
(positive)
Change from FY21 to FY25
millions USD
FY21:
254
FY22:
228
FY23:
137
FY24:
146
FY25:
74.4
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
267
FY22:
235
FY23:
152
FY24:
158
FY25:
118
All amounts in millions USD